Pharmacyte Biotech Inc. buy Sievi
Start price
25.08.21
/
50%
€3.05
Target price
25.08.22
-
Performance (%)
-8.85%
End price
14.09.21
€2.78
Summary
This prediction ended on 14.09.21 with a price of €2.78. With a performance of -8.85%, the BUY prediction for Pharmacyte Biotech Inc. by Sievi closed slightly in the red. Sievi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pharmacyte Biotech Inc. | - | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
According to Sievi what are the pros and cons of Pharmacyte Biotech Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
